FIELD: medicine, pharmacy.
SUBSTANCE: invention relates to pharmaceutical or dietetic composition for reducing level of IGF-I in mammal blood that involves effective amount of carotinoid lycopene reducing the level of IGF-I. Also, invention provides reducing levels of IGF-I that involves administration in subject of lycopene in effective dose, if necessary, and reducing the level of IGF-I. The advantage of invention involves the development of preparation reducing the level of IGF-I in mammal blood effectively.
EFFECT: valuable properties of composition.
14 cl, 1 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
APPLICATION OF COMPOSITIONS, CAPABLE TO RAISE LEVEL OF IGF-1 IN BLOOD SERUM, AT PREPARATION OF THERAPEUTIC COMPOSITION FOR TREATMENT OF STAGES OF VARIOUS DISEASES, ASSOCIATED WITH DEPRESSION OF IGF-1 LEVEL IN SERUM OF PEOPLE AND ANIMALS | 2003 |
|
RU2361583C2 |
SYNERGETIC COMBINATIONS FOR TREATING HYPERTENSION | 2008 |
|
RU2459617C2 |
CAROTINOIDS AS ANTI-HYPERTENSIVE AGENTS | 2002 |
|
RU2290174C2 |
ANTIBODY AGAINST IGF-I RECEPTOR | 2018 |
|
RU2785305C2 |
CAROTINOID-CONTAINING ANTI-ATHEROSCLEROTIC COMPOSITION AND METHOD FOR INHIBITION OF OXIDATION OF LOW DENSITY LIPOPROTEIN (LDL) | 2002 |
|
RU2288707C2 |
COMPOSITIONS SUITABLE TO TREAT DERMAL SIGNS OF AGING | 2005 |
|
RU2409290C2 |
TREATMENT METHODS WHICH REQUIRE PHYTOCOMPONENTS | 2005 |
|
RU2394576C2 |
SYNERGISTIC COMBINATIONS OF CAROTENOIDS AND POLYPHENOLS | 2010 |
|
RU2563991C2 |
IMPROVED METHOD FOR PRODUCING LYCOPENE VIA FERMENTATION OF SELECTED STRAINS Blakeslea trispora AND USING THUS OBTAINED LYCOPENE | 2002 |
|
RU2296161C2 |
REDUCTION OF ARGINASE LEVELS/ACTIVITY | 2007 |
|
RU2469742C2 |
Authors
Dates
2004-12-20—Published
2000-03-29—Filed